4//SEC Filing
Exton Michael 4
Accession 0001127602-25-005209
CIK 0001062822other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:16 PM ET
Size
7.9 KB
Accession
0001127602-25-005209
Insider Transaction Report
Form 4
Exton Michael
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-13+2,264,690→ 2,264,690 totalExercise: $0.69Exp: 2035-02-13→ Common Stock (2,264,690 underlying) - Award
Restricted Stock Units
2025-02-13+1,509,790→ 1,509,790 total→ Common Stock (1,509,790 underlying)
Footnotes (3)
- [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0002029249
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:16 PM ET
- Size
- 7.9 KB